Piramal Pharma Limited
شراء

PPLPHARMA

385
IMPORTANT POINTS

1. RSI - 60 CROSSED ON MONTHLY CHART
2. CUP BREAKOUT OVER ONE YEAR
3. SECTOR BREAKOUT
4. Trading at 35.2% below our estimate of its fair value

FUNDAMENTALS

Below Fair Value

Significantly Below Fair Value

Price-To-Sales vs Peers

Price-To-Sales vs Industry

Price-To-Sales vs Fair Ratio
ملاحظة
start breakout lets see
ملاحظة
10% upward
ملاحظة
become a rocket now
ملاحظة
17 percent up
ملاحظة
1 ST TARGET ACHIVE

إخلاء المسؤولية

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.